These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3710629)

  • 1. Screening for the influence of host factors on warfarin clearance using a single dose single sample procedure.
    Bachmann K
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):167-70. PubMed ID: 3710629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of microdosing to predict pharmacokinetics at the therapeutic dose: experience with 5 drugs.
    Lappin G; Kuhnz W; Jochemsen R; Kneer J; Chaudhary A; Oosterhuis B; Drijfhout WJ; Rowland M; Garner RC
    Clin Pharmacol Ther; 2006 Sep; 80(3):203-15. PubMed ID: 16952487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of single sample clearance estimates to probe hepatic drug metabolism in rats. I.
    Bachmann KA; Yang C; Jahn D; Schwartz J
    Xenobiotica; 1988 Feb; 18(2):151-9. PubMed ID: 3131969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus.
    Staatz CE; Tett SE
    Eur J Clin Pharmacol; 2002 Dec; 58(9):597-605. PubMed ID: 12483452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single dose phenytoin clearance during erythromycin treatment.
    Bachmann K; Schwartz JI; Forney RB; Jauregui L
    Res Commun Chem Pathol Pharmacol; 1984 Nov; 46(2):207-17. PubMed ID: 6515115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single sample estimate of ethosuximide clearance.
    Bachmann K; Schwartz J; Sullivan T; Jauregui L
    Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):546-50. PubMed ID: 3781674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of single sample clearance estimates to probe hepatic drug metabolism in rats. II.
    Bachmann KA; Jahn D; Yang C; Schwartz J
    Xenobiotica; 1988 Feb; 18(2):161-7. PubMed ID: 3131970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of human pharmacokinetics--improving microsome-based predictions of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Oct; 59(10):1427-31. PubMed ID: 17910819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of single sample clearance estimates to probe hepatic drug metabolism: handprinting the influence of cigarette smoking on human hepatic drug metabolism.
    Bachmann KA; Nunlee M; Martin M; Schwartz J; Jauregui L; Forney RB
    Xenobiotica; 1990 May; 20(5):537-47. PubMed ID: 2112290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of single-sample clearance estimates to probe hepatic drug metabolism in rats. IV. A model for possible application to phenotyping xenobiotic influences on human drug metabolism.
    Bachmann KA
    Xenobiotica; 1989 Dec; 19(12):1449-59. PubMed ID: 2618092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apparent clearance of sirolimus in heart transplant recipients: impact of primary diagnosis and serum lipids.
    Zahir H; Keogh AM; Akhlaghi F
    Ther Drug Monit; 2006 Oct; 28(5):614-22. PubMed ID: 17038875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation.
    Staatz CE; Willis C; Taylor PJ; Lynch SV; Tett SE
    Liver Transpl; 2003 Feb; 9(2):130-7. PubMed ID: 12548506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of aging on serum phenytoin concentrations: a pharmacokinetic analysis based on therapeutic drug monitoring data.
    Battino D; Croci D; Mamoli D; Messina S; Perucca E
    Epilepsy Res; 2004; 59(2-3):155-65. PubMed ID: 15246117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of oral busulfan in children.
    Schiltmeyer B; Klingebiel T; Schwab M; Mürdter TE; Ritter CA; Jenke A; Ehninger G; Gruhn B; Würthwein G; Boos J; Hempel G
    Cancer Chemother Pharmacol; 2003 Sep; 52(3):209-16. PubMed ID: 12811512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of tacrolimus in adult kidney transplant recipients.
    Staatz CE; Willis C; Taylor PJ; Tett SE
    Clin Pharmacol Ther; 2002 Dec; 72(6):660-9. PubMed ID: 12496747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of raltitrexed in patients with advanced solid tumours.
    Blair EY; Rivory LP; Clarke SJ; McLachlan AJ
    Br J Clin Pharmacol; 2004 Apr; 57(4):416-26. PubMed ID: 15025739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the interaction of 3S-hydroxy-10,11-dihydroquinidine on the pharmacokinetics and pharmacodynamics of warfarin.
    Trenk D; Möhrke W; Warth L; Jähnchen E
    Arzneimittelforschung; 1993 Aug; 43(8):836-41. PubMed ID: 8216438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steady-state clearance rates of warfarin and its enantiomers in therapeutically dosed patients.
    McAleer SD; Foondun AS; Feely M; Chrystyn H
    Chirality; 1997; 9(1):13-6. PubMed ID: 9094197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The suitability of carbamazepine as a single-sample probe of human mixed function oxidase activity.
    Bachmann KA; Schwartz JI; Jauregui L
    Xenobiotica; 1989 Jul; 19(7):711-9. PubMed ID: 2773507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.